Company / Current Liabilities per Share
Trevi Therapeutics, Inc. Current Liabilities per Share History
FY2018-FY2024 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Liabilities per Share
$0.10
FY2024
5-year range
$0.06 / $0.56
FY2020-FY2024
Trend
+75.2%
vs FY2023
Sector context
#204 of 210
Health Care
What the data says
Among 210 Health Care companies, Trevi Therapeutics, Inc. is in the top 3% for current liabilities per share. Current Liabilities per Share returned to growth in FY2024 after 2 years of decline, reaching $0.10.
Based on SEC 10-K filings.
0.10 in FY2024 with a 5-year CAGR of -25.3%.
Improved from $0.21 to $0.10 over the past 2 years.
Health Care sector context is included.
Current Liabilities per Share over time
Growth rates
- 3-Year CAGR
- -43.0%
- 5-Year CAGR
- -25.3%
- 10-Year CAGR
- -
Sector benchmark
Top 3% in Health CareTop 3% of 210This company $0.10 Sector average $23.79
▼
-99.6% below sector average
Key checks
Key Insights
- In FY2024, current liabilities per share increased 75.2% year-over-year.
- Ranks #204 out of 210 companies in the Health Care sector.
- Peak current liabilities per share was recorded in FY2018.
- Lowest current liabilities per share in the period was in FY2023.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- Altman Z-Score 2.91 (safe zone, above 2.9 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current Liabilities per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2024 | $0.10 | +75.2% |
| FY2023 | $0.06 | -71.7% |
| FY2022 | $0.21 | -62.7% |
| FY2021 | $0.56 | +81.1% |
| FY2020 | $0.31 | -30.6% |
| FY2019 | $0.44 | -92.8% |
| FY2018 | $6.12 | - |
As of FY2024 · SEC 10-K · Updated Feb 28, 2026